Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity
- PMID: 20207715
- DOI: 10.1093/intimm/dxq023
Preventing AID, a physiological mutator, from deleterious activation: regulation of the genomic instability that is associated with antibody diversity
Abstract
Activation-induced cytidine deaminase (AID) is essential and sufficient to accomplish class-switch recombination and somatic hypermutation, which are two genetic events required for the generation of antibody-mediated memory responses. However, AID can also introduce genomic instability, giving rise to chromosomal translocation and/or mutations in proto-oncogenes. It is therefore important for cells to suppress AID expression unless B lymphocytes are stimulated by pathogens. The mechanisms for avoiding the accidental activation of AID and thereby avoiding genomic instability can be classified into three types: (i) transcriptional regulation, (ii) post-transcriptional regulation and (iii) target specificity. This review summarizes the recently elucidated comprehensive transcriptional regulation mechanisms of the AID gene and the post-transcriptional regulation that may be critical for preventing excess AID activity. Finally, we discuss why AID targets not only Igs but also other proto-oncogenes. AID targets many genes but it is not totally promiscuous and the criteria that specify its targets are unclear. A recent finding that a non-B DNA structure forms upon a decrease in topoisomerase 1 expression may explain this paradoxical target specificity determination. Evolution has chosen AID as a mutator of Ig genes because of its efficient DNA cleavage activity, even though its presence increases the risk of genomic instability. This is probably because immediate protection against pathogens is more critical for species survival than complete protection from the slower acting consequences of genomic instability, such as tumor formation.
Similar articles
-
Activation-induced deaminase: light and dark sides.Trends Mol Med. 2006 Sep;12(9):432-9. doi: 10.1016/j.molmed.2006.07.001. Epub 2006 Jul 24. Trends Mol Med. 2006. PMID: 16861038 Review.
-
Oncogenic events triggered by AID, the adverse effect of antibody diversification.Carcinogenesis. 2007 Dec;28(12):2427-33. doi: 10.1093/carcin/bgm201. Epub 2007 Sep 4. Carcinogenesis. 2007. PMID: 17804422 Review.
-
DNA targets of AID evolutionary link between antibody somatic hypermutation and class switch recombination.Adv Immunol. 2009;101:163-89. doi: 10.1016/S0065-2776(08)01005-5. Adv Immunol. 2009. PMID: 19231595 Review.
-
The recruitment of activation induced cytidine deaminase to the immunoglobulin locus by a regulatory element.Mol Immunol. 2010 May;47(9):1860-5. doi: 10.1016/j.molimm.2010.02.025. Epub 2010 Mar 23. Mol Immunol. 2010. PMID: 20334924
-
An evolutionary view of the mechanism for immune and genome diversity.J Immunol. 2012 Apr 15;188(8):3559-66. doi: 10.4049/jimmunol.1102397. J Immunol. 2012. PMID: 22492685 Review.
Cited by
-
Inflammation-mediated genomic instability: roles of activation-induced cytidine deaminase in carcinogenesis.Cancer Sci. 2012 Jul;103(7):1201-6. doi: 10.1111/j.1349-7006.2012.02293.x. Epub 2012 May 11. Cancer Sci. 2012. PMID: 22469133 Free PMC article. Review.
-
AID downregulation is a novel function of the DNMT inhibitor 5-aza-deoxycytidine.Oncotarget. 2014 Jan 15;5(1):211-23. doi: 10.18632/oncotarget.1319. Oncotarget. 2014. PMID: 24457556 Free PMC article.
-
Acquisition of Genetic Aberrations by Activation-Induced Cytidine Deaminase (AID) during Inflammation-Associated Carcinogenesis.Cancers (Basel). 2011 Jun 22;3(2):2750-66. doi: 10.3390/cancers3022750. Cancers (Basel). 2011. PMID: 24212831 Free PMC article.
-
Activation-induced cytidine deaminase: in sickness and in health.J Cancer Res Clin Oncol. 2020 Nov;146(11):2721-2730. doi: 10.1007/s00432-020-03348-x. Epub 2020 Aug 9. J Cancer Res Clin Oncol. 2020. PMID: 32772231 Free PMC article. Review.
-
Activation-induced cytidine deaminase an antibody diversification enzyme interacts with chromatin modifier UBN1 in B-cells.Sci Rep. 2023 Nov 10;13(1):19615. doi: 10.1038/s41598-023-46448-7. Sci Rep. 2023. PMID: 37949972 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources